The state of global immunisation
The latest WHO and UNICEF estimates suggest immunisation coverage is improving, particularly in lower-income countries.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreCancer breakthrough as personalised mRNA vaccine stops melanoma returning
An mRNA vaccine built from patients’ own tumours has reportedly kept melanoma from returning, in a late-stage trial.
Nigeria's Borno State is wrestling its worst cholera outbreak in two decades
An ongoing cholera outbreak in north-east Nigeria has sickened tens of thousands, but the health system and its partners are racing against time to curb it.
In Oyo State schools, the climate-health link is on the curriculum
Climate change is here, and it’s driving disease. In southwestern Nigeria, an education programme teaches children what they can do today to better protect their communities.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allGavi commits additional funding for Ebola response
Gavi, the Vaccine Alliance will provide US$ 7 million to fund a shipment of 70,000 doses of the Ervebo vaccine to DRC.
Gavi, the Vaccine Alliance welcomes the news that the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease (BVD) outbreak response recommends that the existing approved Ebola vaccine.
Gavi welcomes United States government commitment to unlock funding for fiscal years 2025 and 2026
Gavi, the Vaccine Alliance welcomes the announcement today by the United States Government that it intends to release US$ 600 million in funding appropriated by Congress for Gavi for fiscal years 2025 and 2026.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
